<p class="MsoNormal"><span style="color:#000000">COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries regardless of income level, today announced the first round of allocation outlining delivery of 237 million doses of the AZ/Oxford vaccine – manufactured by AstraZeneca and Serum Institute of India – to 142 countries by the end of May.</span></p>
